drugset / Trial / NCT06942936

A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants

NCT06942936

Phase 1 Completed 51 enrolled AstraZeneca Parexel · collab
Non-randomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to assess the impact of multiple doses of itraconazole on the pharmacokinetics (PK) of AZD5004 in healthy participants (Part A), and to assess the impact of multiple doses of AZD5004 on the PK of Combined Oral Contraceptives (COCs) in healthy female participants (Part B).

Timeline

Start
2025-05-28
Primary completion
2026-01-28
Completion
2026-01-28

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5004 Unknown Oral
Subject Itraconazole Small molecule Oral
Subject Levonorgestrel Small molecule 0.15 mg Oral
Subject ethinyl estradiol Small molecule 0.03 mg Oral

Indications

No indication recorded.